Balance Labs, INC. (BLNC) — SEC Filings

Q: What are the key financial highlights for Balance Labs, INC.?

Key financial highlights for Balance Labs, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Balance Labs, INC.?

Key executives at Balance Labs, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Balance Labs, INC. stock?

Risk factors for Balance Labs, INC. (BLNC) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Balance Labs, INC.?

Forward-looking statements and predictions from Balance Labs, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Balance Labs, INC.. Recent 10-K filing on Apr 10, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Balance Labs, INC. on SEC EDGAR

Overview

Balance Labs, INC. (BLNC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Apr 10, 2026: Balance Labs, Inc. filed its 10-K annual report on April 10, 2026, for the fiscal year ending December 31, 2025. The company, primarily involved in management consulting services, is incorporated in Delaware and headquartered in Miami Beach, Florida. The filing includes various exhibits such as fina

Sentiment Summary

Across 13 filings, the sentiment breakdown is: 2 bearish, 11 neutral. The dominant filing sentiment for Balance Labs, INC. is neutral.

Filing Type Overview

Balance Labs, INC. (BLNC) has filed 3 10-K, 4 8-K, 6 10-Q with the SEC between Apr 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (13)

Balance Labs Files 2025 10-K Annual Report — 10-K · Apr 10, 2026 Risk: low
Balance Labs, Inc. filed its 10-K annual report on April 10, 2026, for the fiscal year ending December 31, 2025. The company, primarily involved in management c
8-K Filing — 8-K · Dec 16, 2025
Balance Labs' Net Loss Skyrockets Amidst Derivative Liabilities — 10-Q · Nov 13, 2025 Risk: high
Balance Labs, Inc. (BLNC) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $3,747,212, a substantial rise from
Balance Labs Reports Director/Officer Changes & Comp. — 8-K · Aug 29, 2025 Risk: medium
Balance Labs, Inc. filed an 8-K on August 29, 2025, reporting events as of August 25, 2025. The filing indicates changes related to the departure or election of
Balance Labs' Losses Mount, Cash Dwindles Amid Going Concern Warning — 10-Q · Aug 14, 2025 Risk: high
Balance Labs, Inc. (BLNC) reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year. The company experienced a net lo
Balance Labs, Inc. Q1 2025 10-Q Filed — 10-Q · May 20, 2025 Risk: low
Balance Labs, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial position, including assets, liabilities, and
Balance Labs, Inc. Files 2024 10-K — 10-K · Apr 15, 2025 Risk: low
Balance Labs, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on April 15, 2025. The company, incorporated in Delaware and headquartered in Mi
Balance Labs Appoints Marcum LLP as New Auditor — 8-K · Dec 13, 2024 Risk: low
On December 9, 2024, Balance Labs, Inc. filed an 8-K report to disclose changes in its certifying accountant. The company has appointed Marcum LLP as its new in
Balance Labs, Inc. Files Q3 2024 10-Q — 10-Q · Nov 19, 2024 Risk: low
Balance Labs, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial information for the third quarter and the first nine mo
Balance Labs Files 10-Q, Details Q2 Financials — 10-Q · Aug 12, 2024 Risk: low
Balance Labs, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial position and performance, including balance sh
Balance Labs Appoints New CEO, COO, and Directors — 8-K · Jul 10, 2024 Risk: medium
On July 3, 2024, Balance Labs, Inc. reported changes in its board of directors and executive officers. The company announced the departure of Director Michael J
Balance Labs, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024 Risk: low
Balance Labs, Inc. (BLNC) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Balance Labs, Inc. filed a 10-Q report for the period ending March 31, 2
Balance Labs, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 15, 2024 Risk: medium
Balance Labs, Inc. (BLNC) filed a Annual Report (10-K) with the SEC on April 15, 2024. Balance Labs, Inc. filed its annual report on Form 10-K for the fiscal ye

Risk Profile

Risk Assessment: Of BLNC's 12 recent filings, 2 were flagged as high-risk, 3 as medium-risk, and 7 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Balance Labs, INC.'s most recent 10-Q filing (Nov 13, 2025):

Revenue: $0
Net Income: -$3,747,212
EPS: -$0.16
Debt-to-Equity: N/A
Cash Position: $4,512
Operating Margin: N/A
Total Assets: $4,560,884
Total Debt: $8,728,825

Key Executives

Michael J. Collins
David M. Glickman
Robert M. Glickman

Industry Context

Balance Labs operates in the consulting sector, which is characterized by its reliance on professional services and client relationships. The industry can be competitive, with success often depending on specialized expertise and market demand for consulting services. Trends may include shifts towards digital transformation consulting and data analytics.

Top Tags

10-Q (4) · financials (4) · 10-K (3) · annual-report (2) · quarterly-report (2) · Balance Labs (2) · Financial Report (2) · management-consulting (1) · Going Concern (1) · Net Loss (1)

Key Numbers

iXBRL 10-K Size: 1204908 — Size of the main 10-K filing document in bytes.
Complete Submission Text File Size: 6448486 — Size of the complete submission text file in bytes.
Net Loss: $3.75M — Increased from $0.41M in 2024, primarily due to derivative losses.
Derivative Liability: $3.30M — New liability in 2025, significantly impacting total liabilities.
Cash and Cash Equivalents: $4.51K — Decreased from $13.2K, indicating severe liquidity issues.
Accumulated Deficit: $9.63M — Increased from $5.88M, highlighting persistent unprofitability.
Working Capital Deficit: $8.68M — Significantly worsened from $5.07M, indicating inability to meet short-term obligations.
Cash Used in Operating Activities: $93.49K — Continued cash burn from operations.
Common Shares Outstanding: 22.45M — Increased from 21.67M due to shares issued for services.
Net Loss per Share: $0.16 — Increased from $0.01, reflecting the larger net loss.
Total Liabilities: $8.73M — Increased from $5.17M, driven by derivative liability and related party advances.
Marketable Securities: $48.63K — Decreased from $82.38K, reducing available liquid assets.
Revenue: $0 — for the three and six months ended June 30, 2025, indicating no operational income
Net Loss (Q2 2025): $(146,142) — increased from $(100,700) in Q2 2024
Net Loss (YTD 2025): $(152,548) — improved from $(217,643) in YTD 2024, primarily due to a gain on settlement of accounts payable

Frequently Asked Questions

What are the latest SEC filings for Balance Labs, INC. (BLNC)?

Balance Labs, INC. has 13 recent SEC filings from Apr 2024 to Apr 2026, including 6 10-Q, 4 8-K, 3 10-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of BLNC filings?

Across 13 filings, the sentiment breakdown is: 2 bearish, 11 neutral. The dominant sentiment is neutral.

Where can I find Balance Labs, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Balance Labs, INC. (BLNC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Balance Labs, INC.?

Key financial highlights from Balance Labs, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for BLNC?

The investment thesis for BLNC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Balance Labs, INC.?

Key executives identified across Balance Labs, INC.'s filings include Michael J. Collins, David M. Glickman, Robert M. Glickman.

What are the main risk factors for Balance Labs, INC. stock?

Of BLNC's 12 assessed filings, 2 were flagged high-risk, 3 medium-risk, and 7 low-risk.

What are recent predictions and forward guidance from Balance Labs, INC.?

Forward guidance and predictions for Balance Labs, INC. are extracted from SEC filings as they are enriched.